SALUS, Ljubljana, d. d. Reports Earnings Results for the First Quarter Ended March 31, 2023
May 14, 2023
Share
SALUS, Ljubljana, d. d. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EUR 140.95 million compared to EUR 125.73 million a year ago. Net income was EUR 2.8 million compared to EUR 4.14 million a year ago.
Basic earnings per share from continuing operations was EUR 26.81 compared to EUR 39.69 a year ago.
Salus Ljubljana dd is a Slovenia-based company engaged in the wholesale and distribution of medical products. The Companyâs portfolio includes pharmaceuticals, medical devices, medical supplies, food supplements, cosmetic products and other health products. The Company's core clients are pharmacies, hospitals and health centers from both Slovenia and abroad. Moreover, Salus Ljubljana dd offers the products to its business partners through the Internet store. The Company also provides additional services related to the registration of medicines and the distribution and storage of pharmaceuticals and other medical products.
SALUS, LJUBLJANA, D. D. 
